DOI QR코드

DOI QR Code

Epigallocatechin Gallate가 인체 유방암 세포인 MDA-MB-231의 세포증식억제에 미치는 영향

Effect of Epigallocatechin Gallate on Inhibition of Cell Proliferation in MDA-MB-231 Human Breast Cancer Cells

  • 홍은정 (단국대학교 식품영양학과) ;
  • 김우경 (단국대학교 기초과학연구소)
  • 발행 : 2007.08.30

초록

본 연구는 녹차의 폴리페놀 성분 중에서 항암효과가 가장 크다고 알려진 EGCG가 인체 유방암 세포 MDA-MB-231의 세포증식억제 기전을 알아보고자 실시하였다. EGCG 처리 농도가 증가할수록 48시간 후에 유방암 세포의 증식이 유의적으로 감소되었다. 세포증식 관련 단백질인 $ErbB_2$, $ErbB_3$, Akt의 단백질 발현은 EGCG의 첨가농도 10 ${\mu}m$ 이상일 때부터 유의적으로 발현이 감소하였고, mRNA 발현은 5 ${\mu}m$ 이상부터 유의적으로 감소되었다. Py20, p-Akt 로 단백질의 인산화를 알아본 결과 EGCG 첨가농도가 증가할수록 $ErbB_2$, $ErbB_3$, Akt 의 인산화가 감소함을 확인할 수 있었다. 본 연구 결과를 종합해 보면 인체 유방암 세포 MDA-MB-231에서 EGCG는 암세포에서 과발현되는 $ErbB_2$, $ErbB_3$, Akt의 세포신호 전달과정 억제를 통하여 암세포의 증식을 억제시키는 것을 알 수 있었다.

Epigallocatechin gallate (EGCG), a principal antioxidant derived from green tea, is one of the most extensively investigated chemopreventive phytochemicals. However, the effect of EGCG on proliferation in MDA-MB-231 breast cancer cell is not well known. We investigated the effect of EGCG on protein and mRNA expression related to cell proliferation in MDA-MB-231 human breast cancer cell lines. We cultured MDA-MB-231 cells in the presence of 0, 5, 10 and 20 ${\mu}m$ of EGCG. EGCG significantly inhibited the cancer cell proliferation (p<0.05). In MDA-MB-231 huamn breast cancer cell, EGCG lowered $ErbB_2$ and $ErbB_3$ protein as well as mRNA expression. In addition, protein and mRNA expression of phosphorylated Akt and total Akt were significantly decreased (p<0.05). We suggest that EGCG inhibits cell proliferation through $ErbB_2$, $ErbB_3$ and Akt cell signaling.

키워드

참고문헌

  1. National Cancer Center. 1995 Cancer statistics in Korea
  2. National Cancer Center. 2002 Cancer statistics in Korea
  3. American Cancer Society. 2000. California Cancer Facts and Figures 2000. American Cancer Society California Division and Public Health Institute, Atlanta
  4. Coldtiz GA, Rosner BA, Speizer FE. 1996. Nurses's Health Study Research Group. Risk factors for breast cancer according to family history of breast cancer. J Natl Cancer Inst 88: 365-371 https://doi.org/10.1093/jnci/88.6.365
  5. Wiseman RA. 2004. Breast cancer: critical data analysis concludes that estrogens are not the cause, however lifestyle changes and alter risk rapidly. J Clin Epidemiol 57: 766-772 https://doi.org/10.1016/j.jclinepi.2003.10.017
  6. Kelsey JL, Gammon MD, John EM. 1993. Reproductive factors and breast cancer. Epidemiol Rev 15: 36-47 https://doi.org/10.1093/oxfordjournals.epirev.a036115
  7. Yang JH. 2005. The Effects of foot reflexology on nausea, vomiting and fatigue of breast cancer patients undergoing chemotherapy. J Korean Acad Nurs 35: 177-185
  8. Fujiki H. 2005. Green tea: health benefits as cancer preventive for humans. Chem Rec 5: 119-132 https://doi.org/10.1002/tcr.20039
  9. Matassarin-Jacobs E. 1989. The nursing licensure process and the NCLEX-RN. Nurse Educ 14: 32-35 https://doi.org/10.1097/00006223-198911000-00008
  10. Shimizu M, Deguchi A, Joe AK, Mckoy JF, Moriwaki H, Weinstein IB. 2005. EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells. J Exp Ther Oncol 5: 69-78
  11. Rice-Evance C. 1999. Implications of the mechanisms of action of tea polyphenols as antioxidants in vitro for chemoprevention in humans. Proc Soc Exp Biol Med 220: 262-266 https://doi.org/10.1046/j.1525-1373.1999.d01-45.x
  12. Hermaez JF, Dashwood RH. 1998. Antimutagenic activity of tea towards 2-hydroxyamino-3-methylimidazo[4,5-f]quinoline: effect of tea concentration and brew time on electrophile scavenging. Mutat Res 402(1-2): 299-306 https://doi.org/10.1016/S0027-5107(97)00309-6
  13. Yamakawa S, Asai T, Uchida T, Matsukawa M, Akizawa T, Oku N. 2004. (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis. Cancer Lett 210: 47-55 https://doi.org/10.1016/j.canlet.2004.03.008
  14. Dong ZG, Ma WY, Huang C, Yang CS. 1997. Inhibition of tumor promoter-induced activator protein-1 activation and cell transformation by tea polyphenols (-)epigallocathechin gallate and theaflavins. Cancer Res 57: 4414-4419
  15. Cao Y, Cao R. 1999. Angiogenesis inhibited by drinking tea. Nature 398: 381 https://doi.org/10.1038/18793
  16. Shimizu M, Deguchi A, Lim JT, Moriwaki H, Kopelovich L, Weinstein IB. 2005. (-)-Epigallocathechin gallate and polyphenon E inhibit growth and activation of epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin Cancer Res 11: 2735-2746 https://doi.org/10.1158/1078-0432.CCR-04-2014
  17. Mittal A, Pate MS, Wylie RC, Tollefsbol TO, Katiyar SK. 2004. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Int J Oncol 24: 703-710
  18. Takada M, Ku Y, Hazuto K, Ajiki T. 2002. Inhibitory effect of epigallocathechin-3-gallate on growth and invasion in human biliary tract carcinoma cells. World J Surg 26: 683-686 https://doi.org/10.1007/s00268-001-0290-2
  19. Cross M, Dexter TM. 1991. Growth factors in development, transformation and tumorigenesis. Cell 64: 271-280 https://doi.org/10.1016/0092-8674(91)90638-F
  20. Masuda M, Suzui M, Lim JT, Weinstein IB. 2003. Epigallocatechin-3-gallate inhibits activation of HER-2/ neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clin Cancer Res 15: 3486-3491
  21. Guo S, Lu J, Subramanian A, Sonenshein GE. 2006. Microarray-assisted pathway analysis identifies mitogen- activated protein kinase signaling as a mediator of resistance to the green tea polyphenol epigallocatechin 3-gallate in her-2/neu-overexpressing breast cancer cells. Cancer Res 15: 5322-5329 https://doi.org/10.1158/0008-5472.CAN-05-4287
  22. Yeh CW, Chen WJ, Chiang CT, Lin-Shiau SY, Lin JK. 2003. Suppression of fatty acid synthase in MCF-7 breast cancer cells by tea and tea polyphenols: a possible mechanism for their hypolipidemic effects. Pharmacogenomics J 3: 267-276 https://doi.org/10.1038/sj.tpj.6500192
  23. Cantley LC. 2002. The phosphoinositide 3-kinase family. Science 296: 1655-1657 https://doi.org/10.1126/science.296.5573.1655
  24. Pianetti S, Guo S, Kavanagh KT, Sonenshein GE. 2002. Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Res 62: 652-655
  25. Sah JF, Balasubramanian S, Eckert RL, Rorke EA. 2003. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J Biol Chem 26: 12755-12762 https://doi.org/10.1074/jbc.M312333200